Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Werdan

Showing results (11-20 of 249) with videos related to

Pageof 25
Sort By:
Deutsches Arzteblatt International|May 12, 2010
Evaluation of medical emergency roomsKarl Werdan
Herz|December 7, 2006
[Required monitoring in the intensive care unit]Uwe Janssens, Karl Werdan
Medizinische Klinik (Munich, Germany : 1983)|October 19, 2004
[Intensive care medicine 2004]Sebastian Reith, Karl Werdan
Annals of Translational Medicine|March 3, 2017
Extracorporeal life support during cardiac arrest and cardiogenic shock-how good is the evidence really?Roland Prondzinsky, Karl Werdan
Journal of Thoracic Disease|May 20, 2017
IABP plus ECMO-Is one and one more than two?Sebastian Nuding, Karl Werdan
Herz|November 29, 2023
[Cardiological care research]Ralf Zahn, Karl Werdan
Autonomic & Autacoid Pharmacology|February 6, 2003
The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonistHarald Loppnow, Karl Werdan, Claudia Werner
The New England Journal of Medicine|January 4, 2013
Intraaortic balloon support for cardiogenic shockHolger Thiele, Uwe Zeymer, Karl Werdan
Expert Review of Cardiovascular Therapy|January 10, 2018
Optimal course of treatment in acute cardiogenic shock complicating myocardial infarctionSebastian Nuding, Karl Werdan, Roland Prondzinsky
Innate Immunity|August 21, 2008
Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanismsHarald Loppnow, Karl Werdan, Michael Buerke
Pageof 25

Showing results (11-20 of 249) with videos related to

Sort By:
Pageof 25
Deutsches Arzteblatt International|May 12, 2010
Evaluation of medical emergency roomsKarl Werdan
Herz|December 7, 2006
[Required monitoring in the intensive care unit]Uwe Janssens, Karl Werdan
Medizinische Klinik (Munich, Germany : 1983)|October 19, 2004
[Intensive care medicine 2004]Sebastian Reith, Karl Werdan
Annals of Translational Medicine|March 3, 2017
Extracorporeal life support during cardiac arrest and cardiogenic shock-how good is the evidence really?Roland Prondzinsky, Karl Werdan
Journal of Thoracic Disease|May 20, 2017
IABP plus ECMO-Is one and one more than two?Sebastian Nuding, Karl Werdan
Herz|November 29, 2023
[Cardiological care research]Ralf Zahn, Karl Werdan
Autonomic & Autacoid Pharmacology|February 6, 2003
The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonistHarald Loppnow, Karl Werdan, Claudia Werner
The New England Journal of Medicine|January 4, 2013
Intraaortic balloon support for cardiogenic shockHolger Thiele, Uwe Zeymer, Karl Werdan
Expert Review of Cardiovascular Therapy|January 10, 2018
Optimal course of treatment in acute cardiogenic shock complicating myocardial infarctionSebastian Nuding, Karl Werdan, Roland Prondzinsky
Innate Immunity|August 21, 2008
Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanismsHarald Loppnow, Karl Werdan, Michael Buerke
Pageof 25